Independent monitors have paused enrolment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment U.S. President Donald Trump recently received.
Posted in
#canadahealth #canadahealthy #canadalistings #canadastory #canadianhealth Health Search Canada Online Listing

